According to Marksans Pharma
's latest financial reports the company has a price-to-book ratio of 4.02.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.79 | 110.76% |
2022-12-31 | 1.80 | -18.48% |
2021-12-31 | 2.20 | -33.6% |
2020-12-31 | 3.32 | 194.08% |
2019-12-31 | 1.13 | -49.47% |
2018-12-31 | 2.23 | -35.6% |
2017-12-31 | 3.47 | -2.54% |
2016-12-31 | 3.56 | -62.34% |
2015-12-31 | 9.45 | -12.28% |
2014-12-31 | 10.8 | 86.78% |
2013-12-31 | 5.77 | -1731.78% |
2012-12-31 | -0.3535 |